Company Data

Context Therapeutics Inc.

Ticker
CNTX
Current Price
$1.39 -4.79%
Market Cap
$22.2M
Price Target
Refer to Report
Volume
33.8K
52wk Range
$0.47 - $1.69
Advanced Market Data

Overview

Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer.

Inbox Intel from Channelchek.

Informed investors make more money. And itโ€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
ยฉ 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.